Abstract
This study evaluated the efficacy of pindolol, a noncardioselective β blocker with intrinsic sympathetic activity, on neurocardiogenic syncope using a head-up tilt-table test in 66 patients. Pindolol was equally effective in men and women and the 2 age groups (>60 and <60 years) of the study cohort. The earliest benefit was seen ≤3 days after initiating treatment. Side effects were better tolerated in younger patients (age <60 years).
Original language | English (US) |
---|---|
Pages (from-to) | 1189-1191 |
Number of pages | 3 |
Journal | American Journal of Cardiology |
Volume | 94 |
Issue number | 9 |
DOIs | |
State | Published - Nov 1 2004 |
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine